Comparison of available treatments for tobacco addiction

Current Psychiatry Reports

Volumn 12, Issue 5, 2010, Pages 433-440

  Herman, Aryeh I ^a   Sofuoglu, Mehmet ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Clinical trials; Nicotine; Nicotine pharmacotherapy; Smoking cessation; Special populations; Tobacco use disorder

Indexed keywords

AMFEBUTAMONE; CLONIDINE; NICOTINE; NICOTINE GUM; NICOTINE LOZENGE; NICOTINE PATCH; NORTRIPTYLINE; PLACEBO; TOBACCO SMOKE; UNCLASSIFIED DRUG; VARENICLINE;

ADOLESCENT SMOKING; AGGRESSION; AGITATION; ALCOHOLISM; BEHAVIOR CHANGE; BEHAVIOR THERAPY; BLURRED VISION; BURN; CIGARETTE SMOKING; CLINICAL TRIAL; COFFEE; COGNITIVE THERAPY; COMORBIDITY; CONSTIPATION; COUGHING; DEPRESSION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG ERUPTION; DRUG HALF LIFE; DRUG INDUCED HEADACHE; FATIGUE; FLATULENCE; FOOD DRUG INTERACTION; FRUIT JUICE; HICCUP; HUMAN; INDIGESTION; INSOMNIA; JAW FATIGUE; MATERNAL SMOKING; MENTAL DISEASE; MOOD CHANGE; MOOD DISORDER; NASAL BURNING; NASAL PRURITUS; NAUSEA; NEUROBIOLOGY; NICOTINE REPLACEMENT THERAPY; NOSE IRRITATION; OPIATE ADDICTION; ORTHOSTATIC HYPOTENSION; PATIENT COMPLIANCE; PATIENT COUNSELING; RECOMMENDED DRUG DOSE; REVIEW; SCHIZOPHRENIA; SEDATION; SEIZURE; SIDE EFFECT; SKIN IRRITATION; SLEEP DISORDER; SMOKING CESSATION; SNEEZING; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; SWEATING; THROAT BURNING; TOBACCO DEPENDENCE; TREMOR; URINE RETENTION; URTICARIA; VIVID DREAM; VOMITING; WEIGHT GAIN; WITHDRAWAL SYNDROME; XEROSTOMIA;

BEHAVIOR THERAPY; BENZAZEPINES; BUPROPION; HUMANS; NICOTINE; NORTRIPTYLINE; QUINOXALINES; SMOKING CESSATION; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 77958176742     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-010-0134-6     Document Type: Review

References (49)

1. SL Thorne A Malarcher E Maurice R Caraballo 2009 Cigarette smoking among adults-United States, 2007 JAMA 301 373 375 1:CAS:528:DC%2BD1MXhtlejt7Y%3D 10.1001/jama.301.4.373
2. BF Grant DS Hasin SP Chou, et al. 2004 Nicotine dependence and psychiatric disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions Arch Gen Psychiatry 61 1107 1115 10.1001/archpsyc.61.11.1107 15520358 (Pubitemid 39463411)
3. •• Fiore MC, Jaén CR, Baker TB, et al.: Treating Tobacco Use and Dependence: 2008 Update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services, Public Health Service; 2008. The clinical practice guidelines are the main resource for treating individuals with tobacco use and dependence. The guidelines are based on the review of literature for most evidence-based treatments.
4. B Le Foll C Wertheim SR Goldberg 2007 High reinforcing efficacy of nicotine in non-human primates PLoS One 2 e230 10.1371/journal.pone.0000230 17311094
5. M Sofuoglu S Yoo KP Hill M Mooney 2008 Self-administration of intravenous nicotine in male and female cigarette smokers Neuropsychopharmacology 33 715 720 1:CAS:528:DC%2BD1cXhvVyktr8%3D 10.1038/sj.npp.1301460 17534380 (Pubitemid 351252695)
6. JA Dani D Bertrand 2007 Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system Annu Rev Pharmacol Toxicol 47 699 729 1:CAS:528:DC%2BD2sXit1alurk%3D 10.1146/annurev.pharmtox.47.120505. 105214 17009926
7. DJ Balfour 2009 The neuronal pathways mediating the behavioral and addictive properties of nicotine Handb Exp Pharmacol 192 209 233 1:CAS:528:DC%2BC3cXhtVKlurfO 10.1007/978-3-540-69248-5-8 19184651
8. MW Quick RA Lester 2002 Desensitization of neuronal nicotinic receptors J Neurobiol 53 457 478 1:CAS:528:DC%2BD38Xps1KlsLk%3D 10.1002/neu.10109 12436413 (Pubitemid 35375579)
9. HD Mansvelder JR Keath DS McGehee 2002 Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas Neuron 33 905 919 1:CAS:528:DC%2BD38Xis1Wrtr8%3D 10.1016/S0896-6273(02)00625-6 11906697 (Pubitemid 34246356)
10. S Mottillo KB Filion P Belisle, et al. 2009 Behavioural interventions for smoking cessation: a meta-analysis of randomized controlled trials Eur Heart J 30 718 730 10.1093/eurheartj/ehn552 19109354
11. PB Clarke 1993 Nicotine dependence-mechanisms and therapeutic strategies Biochem Soc Symp 59 83 95 1:STN:280:DyaK2c3ltVaksw%3D%3D 8192688
12. Physicians Desk Reference. Montvale, NJ: Medical Economics Data; 2010.
13. JH Choi CM Dresler MR Norton KR Strahs 2003 Pharmacokinetics of a nicotine polacrilex lozenge Nicotine Tob Res 5 635 644 1:CAS:528: DC%2BD3sXosVGisrs%3D 10.1080/1462220031000158690 14577980 (Pubitemid 37304838)
14. S Shiffman RV Fant AR Buchhalter, et al. 2005 Nicotine delivery systems Expert Opin Drug Deliv 2 563 577 1:CAS:528:DC%2BD2MXlsFShtr8%3D 10.1517/17425247.2.3.563 16296775 (Pubitemid 41683228)
15. V Kaufmann C Jepson M Rukstalis, et al. 2004 Subjective effects of an initial dose of nicotine nasal spray predict treatment outcome Psychopharmacology (Berl) 172 271 276 1:CAS:528:DC%2BD2cXitVOitbg%3D 10.1007/s00213-003-1659-8 (Pubitemid 38392319)
16. P Tonnesen J Norregaard K Mikkelsen, et al. 1993 A double-blind trial of a nicotine inhaler for smoking cessation JAMA 269 1268 1271 1:STN:280: DyaK3s7nt1CrsA%3D%3D 10.1001/jama.269.10.1268 8437304 (Pubitemid 23067430)
17. ME Mooney M Sofuoglu 2006 Bupropion for the treatment of nicotine withdrawal and craving Expert Rev Neurother 6 965 981 1:CAS:528: DC%2BD28Xns1Crtbk%3D 10.1586/14737175.6.7.965 16831112 (Pubitemid 44060292)
18. JT Hays JO Ebbert 2003 Bupropion sustained release for treatment of tobacco dependence Mayo Clin Proc 78 1020 1024 1:CAS:528:DC%2BD3sXmvFShs7o%3D 10.4065/78.8.1020 12911050 quiz 1024
19. JR Hughes LF Stead T Lancaster 2007 Antidepressants for smoking cessation Cochrane Database Syst Rev 1 CD000031 17253443
20. H Rollema M Hajos PA Seymour, et al. 2009 Preclinical pharmacology of the alpha4beta2 nAChR partial agonist varenicline related to effects on reward, mood and cognition Biochem Pharmacol 78 813 824 1:CAS:528:DC%2BD1MXhtVSmsLfM 10.1016/j.bcp.2009.05.033 19501054
21. M Sofuoglu AI Herman M Mooney AJ Waters 2009 Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans Psychopharmacology (Berl) 207 153 162 1:CAS:528:DC%2BD1MXhtVWrsbzJ 10.1007/s00213-009-1643-z
22. R Niaura JT Hays DE Jorenby, et al. 2008 The efficacy and safety of varenicline for smoking cessation using a flexible dosing strategy in adult smokers: a randomized controlled trial Curr Med Res Opin 24 1931 1941 1:CAS:528:DC%2BD1cXhtVGhsLbK 10.1185/03007990802177523 18513462
23. AV Prochazka MJ Weaver RT Keller, et al. 1998 A randomized trial of nortriptyline for smoking cessation Arch Intern Med 158 2035 2039 1:CAS:528:DyaK1cXmvF2rur4%3D 10.1001/archinte.158.18.2035 9778204 (Pubitemid 28465629)
24. SM Hall VI Reus RF Munoz, et al. 1998 Nortriptyline and cognitive-behavioral therapy in the treatment of cigarette smoking Arch Gen Psychiatry 55 683 690 1:CAS:528:DyaK1cXlsF2htbc%3D 10.1001/archpsyc.55.8.683 9707377 (Pubitemid 28364383)
25. WH Frishman 2009 Smoking cessation pharmacotherapy Ther Adv Cardiovasc Dis 3 287 308 10.1177/1753944709335754 19491139
26. SG Gourlay LF Stead NL Benowitz 2004 Clonidine for smoking cessation Cochrane Database Syst Rev 3 CD000058 15266422
27. AH Glassman LS Covey GW Dalack, et al. 1993 Smoking cessation, clonidine, and vulnerability to nicotine among dependent smokers Clin Pharmacol Ther 54 670 679 1:STN:280:DyaK2c7gtFOrtw%3D%3D 10.1038/clpt.1993.205 8275622
28. ME Piper SS Smith TR Schlam, et al. 2009 A randomized placebo-controlled clinical trial of 5 smoking cessation pharmacotherapies Arch Gen Psychiatry 66 1253 1262 10.1001/archgenpsychiatry.2009.142 19884613
29. CT Sweeney RV Fant KO Fagerstrom, et al. 2001 Combination nicotine replacement therapy for smoking cessation: rationale, efficacy and tolerability CNS Drugs 15 453 467 1:CAS:528:DC%2BD3MXlsVOlsL4%3D 10.2165/00023210-200115060- 00004 11524024
30. SM Hall JJ Prochaska 2009 Treatment of smokers with co-occurring disorders: emphasis on integration in mental health and addiction treatment settings Annu Rev Clin Psychol 5 409 431 10.1146/annurev.clinpsy.032408.153614 19327035
31. CW Colton RW Manderscheid 2006 Congruencies in increased mortality rates, years of potential life lost, and causes of death among public mental health clients in eight states Prev Chronic Dis 3 A42 16539783
32. JY Tsoh GL Humfleet RF Munoz, et al. 2000 Development of major depression after treatment for smoking cessation Am J Psychiatry 157 368 374 1:STN:280:DC%2BD3c7mtl2gsQ%3D%3D 10.1176/appi.ajp.157.3.368 10698811 (Pubitemid 30145921)
33. JJ Prochaska SM Hall JY Tsoh, et al. 2008 Treating tobacco dependence in clinically depressed smokers: effect of smoking cessation on mental health functioning Am J Public Health 98 446 448 10.2105/AJPH.2006.101147 17600251 (Pubitemid 351354511)
34. AE Evins C Cather MA Culhane, et al. 2007 A 12-week double-blind, placebo-controlled study of bupropion SR added to high-dose dual nicotine replacement therapy for smoking cessation or reduction in schizophrenia J Clin Psychopharmacol 27 380 386 1:CAS:528:DC%2BD2sXns1Cmt7s%3D 10.1097/01.jcp. 0b013e3180ca86fa 17632223 (Pubitemid 47075510)
35. TP George JC Vessicchio KA Sacco, et al. 2008 A placebo-controlled trial of bupropion combined with nicotine patch for smoking cessation in schizophrenia Biol Psychiatry 63 1092 1096 1:CAS:528:DC%2BD1cXmtVagsrc%3D 10.1016/j.biopsych.2007.11.002 18096137
36. JJ Prochaska K Delucchi SM Hall 2004 A meta-analysis of smoking cessation interventions with individuals in substance abuse treatment or recovery J Consult Clin Psychol 72 1144 1156 10.1037/0022-006X.72.6.1144 15612860 (Pubitemid 39658547)
37. AM Joseph ML Willenbring SM Nugent DB Nelson 2004 A randomized trial of concurrent versus delayed smoking intervention for patients in alcohol dependence treatment J Stud Alcohol 65 681 691 15700504
38. ME Mooney J Poling G Gonzalez, et al. 2008 Preliminary study of buprenorphine and bupropion for opioid-dependent smokers Am J Addict 17 287 292 10.1080/10550490802138814 18612883 (Pubitemid 351957668)
39. Poling J, Rounsaville BJ, Gonsai K, et al.: The safety and efficacy of varenicline in cocaine using smokers maintained on methadone: a pilot study. Am J Addict 2010 (in press).
40. VT Tong JR Jones PM Dietz, et al. 2009 Trends in smoking before, during, and after pregnancy-Pregnancy Risk Assessment Monitoring System (PRAMS), United States, 31 sites, 2000-2005 MMWR Surveill Summ 58 1 29
41. GJ Colman T Joyce 2003 Trends in smoking before, during, and after pregnancy in ten states Am J Prev Med 24 29 35 10.1016/S0749-3797(02)00574-3 12554021 (Pubitemid 36110691)
42. JR DiFranza CA Aligne M Weitzman 2004 Prenatal and postnatal environmental tobacco smoke exposure and childrens health Pediatrics 113 1007 1015 15060193
43. CA Oncken HR Kranzler 2009 What do we know about the role of pharmacotherapy for smoking cessation before or during pregnancy? Nicotine Tob Res 11 1265 1273 1:CAS:528:DC%2BD1MXhtlSgsrzO 10.1093/ntr/ntp136 19717542
44. ER Park Y Chang V Quinn, et al. 2009 The association of depressive, anxiety, and stress symptoms and postpartum relapse to smoking: a longitudinal study Nicotine Tob Res 11 707 714 10.1093/ntr/ntp053 19436040
45. L Marshall M Schooley H Ryan, et al. 2006 Youth tobacco surveillance-United States, 2001-2002 MMWR Surveill Summ 55 1 56 16708059
46. SA Everett CW Warren D Sharp, et al. 1999 Initiation of cigarette smoking and subsequent smoking behavior among U.S. high school students Prev Med 29 327 333 1:STN:280:DC%2BD3c%2Fjtl2hug%3D%3D 10.1006/pmed.1999.0560 10564623
47. S Sussman P Sun CW Dent 2006 A meta-analysis of teen cigarette smoking cessation Health Psychol 25 549 557 10.1037/0278-6133.25.5.549 17014271 (Pubitemid 44600915)
48. D Lawrence F Mitrou SR Zubrick 2009 Smoking and mental illness: results from population surveys in Australia and the United States BMC Public Health 9 285 10.1186/1471-2458-9-285 19664203
49. JR Hughes 2003 Motivating and helping smokers to stop smoking J Gen Intern Med 18 1053 1057 10.1111/j.1525-1497.2003.20640.x 14687265 (Pubitemid 38091401)